Axio Biosolutions
Axio Biosolutions is a global leader in biomaterial-based medical devices, dedicated to revolutionizing wound care and surgical care. Their mission is to improve patient outcomes through advanced wound care and instant bleeding control, with a vision to build innovative medical products that save lives and provide patient comfort. They develop novel solutions for trauma, surgical, and chronic wounds, including bioactive haemostatic dressings like Axiostat and advanced wound dressings like MaxioCel. The company emphasizes quality, compliance with international standards, and has a strong global presence in over 50 countries. Axio Biosolutions is committed to continuous innovation, research, and education in the medical field.
Industries
Nr. of Employees
medium (51-250)
Axio Biosolutions
Patents
Products
Topical haemostatic dressings (chitosan-based)
Sterile single‑use haemostatic dressings made from chitosan-based biomaterials in sponges, Z-fold and rolled gauze formats for external and procedural bleeding control across trauma, surgical, dental and vascular applications.
Advanced absorbent wound dressings (microfiber gelling)
Highly absorbent antimicrobial non-woven microfiber dressings that gel on contact with exudate to manage moisture, reduce pain on removal and support healing in chronic and acute wounds.
Topical haemostatic dressings (chitosan-based)
Sterile single‑use haemostatic dressings made from chitosan-based biomaterials in sponges, Z-fold and rolled gauze formats for external and procedural bleeding control across trauma, surgical, dental and vascular applications.
Advanced absorbent wound dressings (microfiber gelling)
Highly absorbent antimicrobial non-woven microfiber dressings that gel on contact with exudate to manage moisture, reduce pain on removal and support healing in chronic and acute wounds.
Services
Theoretical and practical training modules for healthcare providers and first responders on early hemorrhage control, wound assessment and application of haemostatic and wound-care dressings.
Collaborative support for clinical case reports, investigator-led evaluations and publication of performance data for haemostatic and wound-care dressings.
Production of public-facing guidance on hand hygiene, safe preparation of alcohol-based sanitizers (emphasizing regulatory recommendations), and wound-care best practices.
Theoretical and practical training modules for healthcare providers and first responders on early hemorrhage control, wound assessment and application of haemostatic and wound-care dressings.
Collaborative support for clinical case reports, investigator-led evaluations and publication of performance data for haemostatic and wound-care dressings.
Production of public-facing guidance on hand hygiene, safe preparation of alcohol-based sanitizers (emphasizing regulatory recommendations), and wound-care best practices.
Expertise Areas
- Hemostasis and topical bleeding-control device development
- Chitosan and bioadhesive polymer biomaterials
- Advanced wound-dressing design for exudate management
- Preclinical and clinical evaluation of wound and haemostatic devices
Key Technologies
- Chitosan-based biomaterials
- Protonation/charge-mediated mucoadhesive technology
- Non-woven microfiber gelling technology
- Sterile single-use dressing formats (sponges, rolls, gauze, pads)
News & Updates
Axiobio participated in EuroPCR 2022, showcasing their innovative wound care and bleeding control solutions.
Axiobio presented their latest advancements in wound management at EWMA 2022.
An article discussing how Axiostat is revolutionizing bleeding control in trauma and surgical settings.
A detailed look at how advanced dressings like MaxioCel are improving pressure ulcer management.
Recognition for innovative contributions in medical technology.
Awarded for excellence in export of medical devices.
Axiobio participated in EuroPCR 2022, showcasing their innovative wound care and bleeding control solutions.
Axiobio presented their latest advancements in wound management at EWMA 2022.
An article discussing how Axiostat is revolutionizing bleeding control in trauma and surgical settings.
A detailed look at how advanced dressings like MaxioCel are improving pressure ulcer management.
Recognition for innovative contributions in medical technology.
Awarded for excellence in export of medical devices.